Cargando…
Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma
SIMPLE SUMMARY: Pancreatic cancer is an aggressive disease with a 5-year survival rate of less than 10%. Current therapies can be ineffective due to immune suppression and fibrosis (tissue scarring) that prevents cancer cells from being killed. This review article discusses the relevance of examinin...
Autores principales: | Malchiodi, Zoe X., Weiner, Louis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865209/ https://www.ncbi.nlm.nih.gov/pubmed/33499238 http://dx.doi.org/10.3390/cancers13030405 |
Ejemplares similares
-
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
por: Zhang, Tianyi, et al.
Publicado: (2022) -
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
por: Vaish, Utpreksha, et al.
Publicado: (2021) -
Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
por: Awaji, Mohammad, et al.
Publicado: (2019) -
Fibroblast
Activation Protein-Targeted Photodynamic
Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic
Ductal Adenocarcinoma
por: Dorst, Daphne N., et al.
Publicado: (2023) -
Yes-Associated Protein Mediates Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
por: Murakami, Shigekazu, et al.
Publicado: (2016)